Bioinformatics analysis and in vitro experiments demonstrated that expression of the lipid metabolism-related gene TIAM2 in LUAD increases the resistance of cancer cells to osimertinib, and cancer cell motility including proliferation, migration, invasion, and drives macrophage M0 to M2 polarization. The gene discussed is TIAM2; the disease is cancer.